ClearanceBrief
Recall Z-0882-2015 ยท GJS Test, Time, Prothrombin

Alere San Diego, Inc.

INRatio 2 Monitors - 0200431 Alere INRatio 2 PT/INR Professional Testing System - 0200432 Alere INRatio 2 PT/INR Home Monitoring System - 0200433 Alere INRatio 2 PT/INR Home Monitoring System - 0200457 Alere INRatio 2 Replacement Monitor - 55112 Alere INRatio 2 Replacement Monitor - 55131 Alere INRatio 2 Replacement Monitor - 55128A Alere INRatio 2 PT/INR Professional Monitoring System The test s

DateJan 3, 2015 (initiated Dec 5, 2014)
StatusTerminated
ReasonIn certain cases, an INRatio PT/INR Monitor system may provide an INR result that is significantly lower than a result obtained using a reference INR system (laboratory method). This issue can arise if the patient has certain medical conditions. It can also occur if the instructions in the labeling for performing the test are not followed.
Root causeUnder Investigation by firm
ActionAn Urgent: Medical Device Correction, dated December 5, 2014, was sent to Healthcare Professionals. The letter identified the affected product and reason for recall. Customers were instructed to: -Ensure they have read and understand the precautions described in the current product labeling (a complete list of product labeling is provided in Appendix A) and the additional precautions in this notice describing medical conditions that may increase the risk of obtaining a (falsely or erroneously) lower than expected INR result. The INRatio PT/INR Monitor system should NOT be used if the pati
Quantity231,967 Test Systems including Monitors
DistributionWorldwide Distribution -- US nationwide, Canada, South America, EU, Asia Pacific, Africa, and Middle East.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K072727INRATIO 2 PT MONITORING SYSTEM
Hemosense, Inc., Oct 26, 2007
K092987INRATIO/INRATIO2 TEST STRIPS
Biosite Incorporated, Jun 11, 2010
K110212INRATIO2 PI/NR MONITORING SYSTEM; INRATIO PT/INR TEST STRIP
Alere San Diego, Inc (Formally Biosite Incorporate, May 1, 2012